Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.40% | 32.97% | 9.65% | -3.10% | -14.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.40% | 32.97% | 9.65% | -3.10% | -14.57% |
| Cost of Revenue | 29.31% | 35.95% | 26.60% | 16.14% | 8.57% |
| Gross Profit | 37.13% | 30.42% | -2.63% | -16.00% | -28.45% |
| SG&A Expenses | 21.08% | 19.12% | 6.47% | -1.78% | -9.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 20.03% | 17.16% | 6.62% | -7.79% | -7.47% |
| Total Operating Expenses | 24.95% | 29.59% | 14.14% | 1.82% | -7.98% |
| Operating Income | 272.14% | 91.78% | -32.63% | -50.85% | -71.74% |
| Income Before Tax | 219.89% | 1,224.20% | 50.46% | 0.08% | -54.61% |
| Income Tax Expenses | 173.52% | 236.65% | 207.64% | -11.44% | -50.68% |
| Earnings from Continuing Operations | 245.11% | 714.75% | 36.49% | 4.04% | -56.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 858.26% | 760.88% | 1,372.07% | -13.06% | -159.63% |
| Net Income | 459.63% | 1,471.13% | 62.61% | 2.54% | -67.44% |
| EBIT | 272.14% | 91.78% | -32.63% | -50.85% | -71.74% |
| EBITDA | 69.24% | 13.40% | -33.62% | -40.41% | -47.84% |
| EPS Basic | 461.11% | 1,600.00% | 66.27% | 3.57% | -67.57% |
| Normalized Basic EPS | 829.17% | 263.64% | -19.01% | -55.15% | -85.71% |
| EPS Diluted | 461.11% | 1,600.00% | 66.27% | 3.57% | -67.57% |
| Normalized Diluted EPS | 829.17% | 263.64% | -19.01% | -55.15% | -85.71% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 163.64% | 65.52% | 65.22% | -3.23% | -15.38% |
| Payout Ratio | -0.70% | -0.89% | 0.11% | 2.52% | -- |